The negative influence of baseline cell-free DNA on long-term survival in DLBCL depends on frontline treatment intensity.

Clinical cancer research : an official journal of the American Association for Cancer Research(2023)

引用 0|浏览13
暂无评分
摘要
In this randomized clinical trial, intensive regimens mitigated the negative influence of high cfDNA levels in de novo DLBCL, relative to R-CHOP.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要